Horizon Therapeutics plc to Release First-Quarter 2022 Financial Results and Host Webcast on May 4, 2022

Rhea-AI Summary

Horizon Therapeutics plc (Nasdaq: HZNP) will release its first-quarter 2022 financial results on May 4, 2022, at 8 a.m. Eastern Time. A live webcast will follow the announcement, allowing management to review financial and operational results. Investors can access the webcast at ir.horizontherapeutics.com, with a replay available two hours post-event. Horizon is dedicated to developing medications for rare, autoimmune, and severe inflammatory diseases, focusing on clinically meaningful therapies.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its first-quarter 2022 financial results on Wednesday, May 4, 2022. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company’s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay of the webcast will be available approximately two hours after the live webcast.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220413006001/en/

Horizon Contact:

Tina Ventura

Senior Vice President, Chief Investor Relations Officer

investor-relations@horizontherapeutics.com

U.S. Media Contact:

Geoff Curtis

Executive Vice President, Corporate Affairs & Chief Communications Officer

media@horizontherapeutics.com

Ireland Media Contact:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When will Horizon Therapeutics release its first-quarter 2022 financial results?

Horizon Therapeutics will release its first-quarter 2022 financial results on May 4, 2022.

What time is the live webcast for Horizon's financial results?

The live webcast for Horizon's financial results will be at 8 a.m. Eastern Time.

Where can I access the replay of Horizon Therapeutics' financial results webcast?

The replay of the webcast can be accessed at ir.horizontherapeutics.com approximately two hours after the live event.

What does Horizon Therapeutics focus on?

Horizon Therapeutics focuses on the discovery, development, and commercialization of medicines for rare, autoimmune, and severe inflammatory diseases.